Financial results - MEDESTET DR. ANCA BAJZAT S.R.L.

Financial Summary - Medestet Dr. Anca Bajzat S.r.l.
Unique identification code: 39416319
Registration number: J2/857/2018
Nace: 8622
Sales - Ron
10.299
Net Profit - Ron
8.425
Employees
Open Account
Company Medestet Dr. Anca Bajzat S.r.l. with Fiscal Code 39416319 recorded a turnover of 2024 of 10.299, with a net profit of 8.425 and having an average number of employees of - . The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Medestet Dr. Anca Bajzat S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 6.245 10.142 16.723 18.617 13.147 10.299
Total Income - EUR - - - - 6.245 10.142 16.723 18.617 13.147 10.299
Total Expenses - EUR - - - - 365 405 112 99 125 297
Gross Profit/Loss - EUR - - - - 5.879 9.737 16.611 18.518 13.022 10.002
Net Profit/Loss - EUR - - - - 5.692 9.450 16.163 18.037 11.168 8.425
Employees - - - - 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -21.2%, from 13.147 euro in the year 2023, to 10.299 euro in 2024. The Net Profit decreased by -2.680 euro, from 11.168 euro in 2023, to 8.425 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Medestet Dr. Anca Bajzat S.r.l.

Rating financiar

Financial Rating -
MEDESTET DR. ANCA BAJZAT S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Medestet Dr. Anca Bajzat S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Medestet Dr. Anca Bajzat S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Medestet Dr. Anca Bajzat S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Medestet Dr. Anca Bajzat S.r.l. - CUI 39416319

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 0 0 0 0 0 746
Current Assets - - - - 5.821 15.144 24.756 25.558 19.374 8.093
Inventories - - - - 0 0 0 0 0 0
Receivables - - - - 0 0 0 204 0 0
Cash - - - - 5.821 15.144 24.756 25.354 19.374 8.093
Shareholders Funds - - - - 5.734 15.075 22.392 25.558 19.068 8.474
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 87 68 2.363 0 307 365
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 8.093 euro in 2024 which includes Inventories of 0 euro, Receivables of 0 euro and cash availability of 8.093 euro.
The company's Equity was valued at 8.474 euro, while total Liabilities amounted to 365 euro. Equity decreased by -10.488 euro, from 19.068 euro in 2023, to 8.474 in 2024.

Risk Reports Prices

Reviews - Medestet Dr. Anca Bajzat S.r.l.

Comments - Medestet Dr. Anca Bajzat S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.